Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants
WALTHAM, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. ("Crescent” or the "Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next…
Read the full articleYou might also wanna read
Crescent Biopharma files ordinary shares offering, no amount given
See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F
thefly.com·2d ago
Biotech NRx to sell new shares to fund growth and operations
#NRXP NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
stocktitan.net·1mo ago
Attovia Therapeutics files for Nasdaq IPO to fund immune-disease biologics
Tao Fu's San Carlos biotech is seeking an ATTO listing before disclosing price range, share count or valuation.
runtimewire.com·2d ago
A Look at Biogen Inc (BIIB) After 5.0% Gain -- GF Value $191.79 vs Price $209.03
Related Stocks: BIIB
GuruFocus·3d ago
Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.
This could be a key move for future growth.
Bars·12d ago
Biocon block deal today: Mylan may sell Rs 3,481 crore worth of shares in pharma major
According to Business Today sources, the floor price has been set at Rs 378.50 per share, a 7.9 per cent discount to Biocon's Monday closing
businesstoday.in·3d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.